NCT01566214

Brief Summary

The purpose of this research study is to survey patients to learn about their beliefs and behaviors related to the management of heart disease and to discuss options for making healthy lifestyle changes. From the information the investigators get from patients, the investigators hope to develop better methods for taking care of patients who have heart disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Apr 2012

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2012

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 29, 2012

Completed
1 month until next milestone

Study Start

First participant enrolled

April 30, 2012

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2012

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2012

Completed
6.2 years until next milestone

Results Posted

Study results publicly available

December 24, 2018

Completed
Last Updated

December 24, 2018

Status Verified

June 1, 2018

Enrollment Period

2 months

First QC Date

March 19, 2012

Results QC Date

June 12, 2018

Last Update Submit

June 12, 2018

Conditions

Keywords

coronary heart disease (CHD)myocardial infarction (MI)acute coronary syndromes (ACS)

Outcome Measures

Primary Outcomes (13)

  • SF-36v Physical Function Scale

    Physical Functioning Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Change from baseline to 3-months post hospital discharge

  • SF-36v Role Limitations Due to Physical Health Scale

    Role Limitations Due to Physical Health Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Change from baseline to 3-months post hospital discharge

  • SF-36v Role Limitations Due to Emotional Problems Scale

    Role Limitations Due to Emotional Problems Scale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Change from baseline to 3-months post hospital discharge

  • SF-36v Energy-Fatigue Scale

    Energy-Fatigue Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Change from baseline to 3-months post hospital discharge

  • SF-36v Emotional Well-Being Scale

    Emotional Well-Being Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Change from baseline to 3-months post hospital discharge

  • SF-36v Social Functioning Scale

    Social Functioning Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Change from baseline to 3-months post hospital discharge

  • SF-36v Pain Scale

    Pain Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Change from baseline to 3-months post hospital discharge

  • SF-36v General Health Scale

    General Health Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Change from baseline to 3-months post hospital discharge

  • Seattle Angina Questionnaire Physical Limitations Scale

    Physical Limitations Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Change from baseline to 3-months post hospital discharge

  • Seattle Angina Questionnaire Angina Stability Scale

    Angina Stability Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Change from baseline to 3-months post hospital discharge

  • Seattle Angina Questionnaire Angina Frequency Scale

    Angina Frequency Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Change from baseline to 3-months post hospital discharge

  • Seattle Angina Questionnaire Treatment Satisfaction Scale

    Treatment Satisfaction Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Change from baseline to 3-months post hospital discharge

  • Seattle Angina Questionnaire Disease Perception Scale

    Disease Perception Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

    Change from baseline to 3-months post hospital discharge

Study Arms (2)

Motivational Interview

EXPERIMENTAL

For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes.

Behavioral: Motivational Interview

Usual Care

NO INTERVENTION

For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.

Interventions

For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes.

Motivational Interview

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Admission to an inpatient medicine unit for MI, ACS, and coronary angiography
  • Age

You may not qualify if:

  • Altered mental status
  • Language barriers
  • Dementia or Cognitive Impairment
  • Diagnostic Study
  • Resident in long-term care facility prior to the present admission
  • Planned discharge to a skilled or intermediate care facility or hospice
  • Lack of access to a functioning phone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Iowa City VA Health Care System, Iowa City, IA

Iowa City, Iowa, 52246-2208, United States

Location

MeSH Terms

Conditions

Heart DiseasesCoronary DiseaseMyocardial InfarctionAcute Coronary Syndrome

Interventions

Motivational Interviewing

Condition Hierarchy (Ancestors)

Cardiovascular DiseasesMyocardial IschemiaVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Intervention Hierarchy (Ancestors)

Directive CounselingCounselingMental Health ServicesBehavioral Disciplines and ActivitiesHealth ServicesHealth Care Facilities Workforce and Services

Results Point of Contact

Title
Mark Vander Weg
Organization
Iowa City VA Health Care System

Study Officials

  • Mark W Vander Weg, PhD MS BA

    Iowa City VA Health Care System, Iowa City, IA

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 19, 2012

First Posted

March 29, 2012

Study Start

April 30, 2012

Primary Completion

June 30, 2012

Study Completion

October 31, 2012

Last Updated

December 24, 2018

Results First Posted

December 24, 2018

Record last verified: 2018-06

Locations